Skip to content

The Effect of Vascular Imaging Devices on Success Rates of Peripheral Vascular Access in Pediatric Patients

The Effect of Vascular Imaging Devices on the Success Rate of Peripheral Vascular Access in Pediatric Patients Undergoing Day-Case and Non-Operating Room Anesthesia Procedures

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07315711
Enrollment
500
Registered
2026-01-02
Start date
2025-12-01
Completion date
2027-12-01
Last updated
2026-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, Crohn's Disease, Peptic Ulcer, Peripheral Vascular Access in Pediatric Patients

Keywords

non-operating room anesthesia (NORA), peripheral vascular access, pediatric patienent

Brief summary

The study was designed as a prospective, observational study. Pediatric patients under 18 years of age scheduled for peripheral vascular access placement during day-case surgery or non-operating room anesthesia (NORA) will be included. The primary outcomes include time to successful vascular access, number of attempts, and number of interventions (defined as each new skin entry of the needle). These outcomes will be compared between two groups: those who receive vascular access with the aid of a vascular imaging device and those in whom such a device is not used.

Interventions

None listed

Sponsors

Sibel Seçkin Pehlivan
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Days to 18 Days
Healthy volunteers
No

Inclusion criteria

* Pediatric patients aged 0-18 years scheduled for day-case surgery or non-operating room anesthesia (NORA) Patients requiring peripheral vascular access (those with a need for intravenous access) Patients whose parent or legal guardian can provide written informed consent Patients suitable for vascular access using a vascular imaging device

Exclusion criteria

Patients requiring emergency surgery or urgent intervention Patients whose parent or legal guardian cannot provide informed consent Patients with local extremity problems such as infection, edema, or wound that prevent peripheral vascular access placement \-

Design outcomes

Primary

MeasureTime frameDescription
The time to establish peripheral vascular accesspre-intervention/procedure/surgeryThe primary outcome measure is the time required to successfully establish peripheral vascular access, defined as the interval from the first needle insertion attempt to the confirmation of intravenous placement (e.g., blood return and/or free flow of saline). This metric will be recorded in seconds and compared between patients who receive vascular imaging assistance and those who do not.
number of attemptspre-intervention/procedure/surgeryThe number of attempts refers to the total number of needle insertions required to achieve successful peripheral vascular access, with each attempt defined as a distinct skin puncture. An attempt is counted even if cannulation is not achieved. This outcome will be documented for each patient and compared between the group using vascular imaging devices and the group without such assistance.

Secondary

MeasureTime frameDescription
number of interventions (each new skin entry of the needle)pre-intervention/procedure/surgeryThe number of interventions refers to the total count of new skin entries made with the needle during peripheral vascular access attempts. Each distinct insertion of the needle through the skin, regardless of whether it occurs during the same cannulation effort or a subsequent repositioning, is recorded as a separate intervention. This metric will be used to assess procedural invasiveness and will be compared between patients who undergo vascular access with versus without vascular imaging device assistance

Countries

Turkey (Türkiye)

Contacts

Primary ContactSibel Seckin Pehlivan, Assistant Professor
sibelpehlivan@erciyes.edu.tr0905052532919
Backup ContactRECEP AKSU, PROFESSOR
sibelpehlivan@erciyes.edu.tr0905337461200

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026